Effect of Serotonin-Related Gene Polymorphisms on Pathogenesis and Treatment Response in Korean Schizophrenic Patients
详细信息 查看全文
- 作者：Yong-Ku Kim (12)
Ho-Kyoung Yoon (1) because@naver.com - 关键词：Korean – ; Polymorphism – ; Serotonin – ; Schizophrenia
- 刊名：Behavior Genetics
- 出版年：2011
- 出版时间：September 2011
- 年：2011
- 卷：41
- 期：5
- 页码：709-715
- 全文大小：179.8 KB
- 参考文献：1. Abdolmaleky HM, Faraone SV, Glatt SJ, Tsuang MT (2004) Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr Res 67(1):53–62
2. Addington D, Addington J, Schissel B (1990) A depression rating scale for schizophrenics. Schizophr Res 3(4):247–251
3. Anttila S, Kampman O, Illi A, Rontu R, Lehtim盲ki T, Leinonen E (2007) Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach. BMC Psychiatry 7:22
4. APA (1994) Diagnostic and statistical manual of mental disorders. In. American Psychiatric Press, Washington DC, p 886
5. Carlsson A (1978) Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 135(2):165–173
6. Chee IS, Lee SW, Kim JL, Wang SK, Shin YO, Shin SC, Lee YH, Hwang HM, Lim MR (2001) 5-HT2A receptor gene promoter polymorphism-1438A/G and bipolar disorder. Psychiatr Genet 11(3):111–114
7. Chen RY, Sham P, Chen EY, Li T, Cheung EF, Hui TC, Kwok CL, Lieh-Mak F, Zhao JH, Collier D, Murray R (2001) No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients. Psychiatry Res 105(3):175–185
8. Chotai J, Serretti A, Lorenzi C (2005) Interaction between the tryptophan hydroxylase gene and the serotonin transporter gene in schizophrenia but not in bipolar or unipolar affective disorders. Neuropsychobiology 51(1):3–9
9. De Luca V, Likhodi O, Van Tol HHM, Kennedy J, Wong AHC (2005) Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia. Psychopharmacology (Berl) 183(3):378–382
10. Fan JB, Sklar P (2005) Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol Psychiatry 10(10):928–938
11. First M, Spitzer RL, Gibbon M, William JB (1998a) Structured clinical interview for DSM-IVAxis I disorders, patient edition (SCID-I/P, version 2.0). Biometrics Research Department, New York State Psychiatric Institute. American Psychiatric Publishing, Inc
12. First M, Spitzer RL, Gibbon M, William JB (1998b) Structured clinical interview for DSM-IVAxis I disorders, non-patient edition (SCID-I/NP, version 2.0). Biometrics Research Department, New York State Psychiatric Institute. American Psychiatric Publishing, Inc
13. Gu B, Wang L, Zhang A-P, Ma G, Zhao X-Z, Li H-F, Feng G-Y, He L, Xing Q-H (2008) Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patients. Pharmacogenet Genomics 18(8):721–727
14. Higashi S, Ohnuma T, Shibata N, Higashi M, Matsubara Y, Arai H (2007) No genetic association between tryptophan hydroxylase 2 gene polymorphisms and Japanese schizophrenia. Psychiatr Genet 17(2):123
15. Hong CJ, Tsai SJ, Wang YC (2001) Association between tryptophan hydroxylase gene polymorphism (A218C) and schizophrenic disorders. Schizophr Res 49(1–2):59–63
16. Hong CJ, Chen TJ, Yu YW, Tsai SJ (2006) Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J 6(1):27–33
17. Hoyer D, Pazos A, Probst A, Palacios JM (1986) Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res 376(1):97–107
18. Ichikawa J, Meltzer HY (1999) R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum. J Pharmacol Exp Ther 291(3):1227–1232
19. Jakab RL, Goldman-Rakic PS (1998) 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 95(2):735–740
20. Kay SR, Opler LA, Lindenmayer JP (1989) The positive and negative syndrome scale (PANSS): rationale and standardisation. Br J Psychiatry 155(Suppl 7):59–67
21. Kendler KS, Diehl SR (1993) The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull 19(2):261–285
22. Kirov G, Zaharieva I, Georgieva L, Moskvina V, Nikolov I, Cichon S, Hillmer A, Toncheva D, Owen MJ, O’Donovan MC (2009) A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol Psychiatry 14(8):796–803
23. Lane H-Y, Chang Y-C, Chiu C-C, Chen M-L, Hsieh M-H, Chang W-H (2002) Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene. Am J Psychiatry 159(9):1593–1595
24. Lewis DA, Lieberman JA (2000) Catching up on schizophrenia: natural history and neurobiology. Neuron 28(2):325–334
25. Li D, He L (2006) Meta-analysis shows association between the tryptophan hydroxylase (TPH) gene and schizophrenia. Hum Genet 120(1):22–30
26. Lidov HG, Molliver ME (1982) An immunohistochemical study of serotonin neuron development in the rat: ascending pathways and terminal fields. Brain Res Bull 8(4):389–430
27. Lieberman JA (1993) Understanding the mechanism of action of atypical antipsychotic drugs. A review of compounds in use and development. Br J Psychiatry 163(Suppl 22):7–18
28. Li茅geois J-F, Ichikawa J, Meltzer HY (2002) 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner. Brain Res 947(2):157–165
29. Lin CH, Tsai SJ, Yu YW, Song HL, Tu PC, Sim CB, Hsu CP, Yang KH, Hong CJ (1999) No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population. Neuroreport 10(1):57–60
30. Lin YM, Chao SC, Chen TM, Lai TJ, Chen JS, Sun HS (2007) Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese. Arch Gen Psychiatry 64(9):1015–1024
31. Lopez VA, Detera-Wadleigh S, Cardona I, Kassem L, McMahon FJ (2007) Nested association between genetic variation in tryptophan hydroxylase II, bipolar affective disorder, and suicide attempts. Biol Psychiatry 61(2):181–186
32. McGuffin P, Owen MJ, Farmer AE (1995) Genetic basis of schizophrenia. Lancet 346(8976):678–682
33. Meltzer HY, Matsubara S, Lee JC (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 251(1):238–246
34. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E, Owen MJ, O’Donovan MC (2009) Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 14(3):252–260
35. M枚ssner R, Freitag CM, Gutknecht L, Reif A, Tauber R, Franke P, Fritze J, Wagner G, Peikert G, Wenda B, Sand P, Rietschel M, Garritsen H, Jacob C, Lesch KP, Deckert J (2006) The novel brain-specific tryptophan hydroxylase-2 gene in panic disorder. J Psychopharmacol (Oxf) 20(4):547–552
36. M枚ssner R, Schuhmacher A, K眉hn K-U, Cvetanovska G, Rujescu D, Zill P, Quednow BB, Rietschel M, W枚lwer W, Gaebel W, Wagner M, Maier W (2009) Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia. Pharmacogenet Genomics 19(1):91–94
37. Nielsen DA, Jenkins GL, Stefanisko KM, Jefferson KK, Goldman D (1997) Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Brain Res Mol Brain Res 45(1):145–148
38. Nocjar C, Roth BL, Pehek EA (2002) Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience 111(1):163–176
39. Ohara K, Nagai M, Tani K, Tsukamoto T (1999) Schizophrenia and the serotonin-2A receptor promoter polymorphism. Psychiatry Res 85(2):221–224
40. Pae C-U, Artioli P, Serretti A, Kim T-S, Kim J-J, Lee C-U, Lee S-J, Lee C, Paik I-H (2005) No evidence for interaction between 5-HT2A receptor and serotonin transporter genes in schizophrenia. Neurosci Res 52(2):195–199
41. Paik I, Toh K, Kim J, Lee C (2000) TPH gene may be associated with suicidal behavior, but not with schizophrenia in the Korean population. Hum Hered 50(6):365–369
42. Patel PD, Pontrello C, Burke S (2004) Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland. Biol Psychiatry 55(4):428–433
43. Pe帽as-Lled贸 EM, Dorado P, C谩ceres MC, de la Rubia A, Llerena A (2007) Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs. Clin Chem Lab Med 45(7):835–838
44. Reynolds GP, Arranz B, Templeman LA, Fertuzinhos S, San L (2006) Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients. Am J Psychiatry 163(10):1826–1829
45. S谩iz PA, Garc铆a-Portilla MP, Arango C, Morales B, Alvarez V, Coto E, Fern谩ndez JM, Bascar谩n MT, Bouso帽o M, Bobes J (2007) Association study of serotonin 2A receptor (5-HT2A) and serotonin transporter (5-HTT) gene polymorphisms with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31(3):741–745
46. Sekizawa T, Iwata Y, Nakamura K, Matsumoto H, Suzuki A, Suzuki K, Sekine Y, Takei N, Minabe Y, Mori N (2004) Childhood-onset schizophrenia and tryptophan hydroxylase gene polymorphism. Am J Med Genet 128B(1):24–26
47. Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E (1999) Lack of association between tryptophan hydroxylase gene and psychotic symptomatology in schizophrenia. Schizophr Res 40(2):171–172
48. Shifman S, Johannesson M, Bronstein M, Chen S, Collier D, Craddock N, Kendler K, Li T, O’Donovan M, O’Neill FA, Owen M, Walsh D, Weinberger D, Sun C, Flint J, Darvasi A (2008) Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 4(2):e28–e28
49. Sodhi MSK, Sanders-Bush E (2004) Serotonin and brain development. Int Rev Neurobiol 59:111–174
50. Wang L, Yu L, He G, Zhang J, Zhang A-P, Du J, Tang R-Q, Zhao X-Z, Ma J, Xuan J-K, Xiao Y, Gu N-F, Feng G-Y, Xu M-Q, Xing Q-H, He L (2007) Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients. Neurosci Lett 414(1):1–4
51. Werkman TR, Glennon JC, Wadman WJ, McCreary AC (2006) Dopamine receptor pharmacology: interactions with serotonin receptors and significance for the aetiology and treatment of schizophrenia. CNS Neurol Disord Drug Targets 5(1):3–23
52. Williams J, McGuffin P, N枚then M, Owen MJ (1997) Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European multicentre association study of Schizophrenia. Lancet 349(9060):1221
53. Willins DL, Deutch AY, Roth BL (1997) Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27(1):79–82
54. Woolley DW, Shaw E (1954) A biochemical and pharmacological suggestion about certain mental disorders. Proc Natl Acad Sci USA 40(4):228–231
55. Zaboli G, J枚nsson EG, Gizatullin R, Asberg M, Leopardi R (2006) Tryptophan hydroxylase-1 gene variants associated with schizophrenia. Biol Psychiatry 60(6):563–569
56. Zill P, B眉ttner A, Eisenmenger W, Bondy B, Ackenheil M (2004) Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains. Eur Neuropsychopharmacol 14(4):282–284 - 作者单位：1. Department of Psychiatry, Korea University Anam Hospital, Anam-dong 5 ga, Seongbuk-gu, Seoul, 136-705 Republic of Korea2. Division of Brain Korea 21 Biomedical Science, Korea University, Seoul, Korea
- 刊物类别：Biomedical and Life Sciences
- 刊物主题：Biomedicine
Human Genetics
Neurosciences
Evolutionary Biology - 出版者：Springer Netherlands
- ISSN：1573-3297
文摘
Serotonin has been implicated in the pathophysiology of several psychiatric disorders including schizophrenia. Serotonergic system-related genes may be good candidates in investigating the genetic basis of schizophrenia. We aimed to investigate the associations of HTR1A C–1019G, HTR2A–1438A/G, TPH1 218A/C, and TPH2–703G/T variants with schizophrenia. A total of 202 patients with schizophrenia and 165 normal controls were genotyped for HTR1A C–1019G, HTR2A–1438A/G, TPH1 218A/C, and TPH2–703G/T single nucleotide polymorphisms (SNPs). In order to assess the severity of a patient’s psychiatric symptoms, the brief psychiatric rating scale (BPRS), the positive and negative symptom scale (PANSS), and the Calgary depression scale for Schizophrenia (CDSS) were administered. Genotype and allele frequencies were compared between groups via χ2 statistics. Associations between the genotypes of candidate SNPs with the severity of symptoms were examined with ANOVA by comparing the mean scores of BPRS, PANSS, and CDSS according to genotype. No significant differences in the genotype distributions and allele frequencies of four SNPs were found between patients with schizophrenia and normal controls. There was a trend towards association of HTR1A C–1019G polymorphism with negative symptom. Negative symptom score of PANSS was lower in the patients with CC genotype than in the G allele carriers. These results suggested that C allele might be associated with lesser negative symptom. More studies are needed to confirm these findings. In the future, we plan to study the associations between schizophrenia and other genetic polymorphisms.